✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Remus Pharmaceuticals Ltd.

REMUS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹801 Cr.
P/E
27.56

Remus Pharmaceuticals Ltd.

  • Remus Pharmaceutical
  • State Trading Corp
  • Veritas (India)

FAQs on Remus Pharmaceuticals Ltd. Shareprice

Remus Pharmaceutical has given lower returns compared to its competitors.
Remus Pharmaceutical has grown at ~-48.67% over the last 1yrs while peers have grown at a median rate of -23.5%

There is insufficient historical data to gauge this.
Latest PE of Remus Pharmaceutical is 27.56

View FAQ's On Business

Growth Table

  • Remus Pharmaceuticals Ltd.
  • State Trading Corp
  • Veritas (India)

Balance Sheet

  • Remus Pharmaceuticals Ltd.
  • State Trading Corp
  • Veritas (India)

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Remus Pharmaceuticals Ltd.
  • State Trading Corp
  • Veritas (India)

Cash Flow

  • Remus Pharmaceuticals Ltd.
  • State Trading Corp
  • Veritas (India)

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Remus Pharmaceuticals Ltd.
  • State Trading Corp
  • Veritas (India)

Quarterly Results

  • Remus Pharmaceuticals Ltd.
  • State Trading Corp
  • Veritas (India)

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Remus Pharmaceuticals Ltd. Financials

Balance sheet of Remus Pharmaceutical is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Remus Pharmaceutical is increasing.
Latest net debt of Remus Pharmaceutical is ₹4.68 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹16.03 Crs.

Yes, profit is increasing.
The profit of Remus Pharmaceutical is ₹29.07 Crs for Mar 2025, ₹20.53 Crs for Mar 2024 and ₹8.5 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Remus Pharmaceutical latest dividend payout ratio is 3.04% and 3yr average dividend payout ratio is 3.3%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech